Prolific

Prolific Machines is a biotechnology company pioneering the use of optogenetics and artificial intelligence to transform biomanufacturing. The company's proprietary Photomolecular™ platform utilizes light to precisely control cellular behavior, allowing for the production of complex biologics such as antibodies, vaccines, and gene therapy vectors without the need for expensive chemical growth factors. By optimizing cell line development and bioprocessing, Prolific Machines aims to lower production costs and increase the accessibility of high-quality therapeutics. The company is currently scaling its technology through partnerships in the biopharmaceutical and advanced nutrition sectors.